GL PharmTech is a leading company in the development of pharmaceutical products with reduced side effects, greater therapeutic efficacy, and improved patient compliance. Since 2002, they have been using their proprietary drug formulation and delivery technologies to provide value-added drug formulations to over 50 pharmaceutical companies in Korea. Their focus is on creating generic and improved versions of currently marketed drugs, particularly in the areas of cardiovascular, gastric, diabetes, CNS, and respiratory diseases. GL PharmTech's expertise lies in incrementally modifying drugs to enhance their effectiveness and minimize side effects, ultimately improving patient outcomes.